LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Sponsor: Eli Lilly and Company
Anaheim, CA · Lancaster, CA · Los Angeles, CA · +37 more sites
16 recruiting ulcerative colitis studies with a site in Los Angeles, CA.
All trials in Los Angeles, CA · All Ulcerative Colitis trials
Sponsor: Eli Lilly and Company
Anaheim, CA · Lancaster, CA · Los Angeles, CA · +37 more sites
Sponsor: Eli Lilly and Company
Los Angeles, CA · Oxnard, CA · +12 more sites
Sponsor: Janssen Research & Development, LLC
Anaheim, CA · Coronado, CA · Lancaster, CA · +53 more sites
Sponsor: Bristol-Myers Squibb
Garden Grove, CA · Loma Linda, CA · Los Angeles, CA · +33 more sites
Sponsor: Takeda
Los Angeles, CA · Newport Beach, CA · +35 more sites
Sponsor: Sanofi
Arcadia, CA · Canoga Park, CA · Coronado, CA · +115 more sites
Sponsor: Cedars-Sinai Medical Center
Los Angeles, CA
Sponsor: Mayo Clinic
Irvine, CA · La Jolla, CA · Los Angeles, CA · +21 more sites
Sponsor: Boomerang Medical
Folsom, CA · Los Angeles, CA · Newport Beach, CA · +16 more sites
Sponsor: Children's Hospital Los Angeles
Los Angeles, CA
Sponsor: Takeda
Los Angeles, CA · San Diego, CA · San Francisco, CA · +19 more sites
Sponsor: University of California, Los Angeles
Los Angeles, CA
Sponsor: Northwestern University
Los Angeles, CA · +12 more sites
Sponsor: University of California, Los Angeles
Los Angeles, CA
Sponsor: Cedars-Sinai Medical Center
Los Angeles, CA
Sponsor: Brennan Spiegel
Los Angeles, CA · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.